Although some anti-diabetic drugs (e.g., metformin, a biguanide) [55-57] as well as caloric restriction [58,59] can partially mimic adiponectin action and induce AMPK signaling in cancer tissues, specific and selective compounds targeting AdipoR still await development. Here, ADIPOQ is linked to cancer.